Literature DB >> 3780839

Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.

L Dodion, J L Willems.   

Abstract

The plasma concentration of torasemide was determined as a function of time in 8 patients with impaired renal function (creatinine clearance less than or equal to 25 ml/min). The elimination half-life (1.3 to 3.8 h), the volume of distribution (0.12 to 0.29 l/kg), and the total body clearance (0.02 to 0.10 l/kg X h) were similar to those observed in normal volunteers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780839     DOI: 10.1007/bf00541467

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.

Authors:  M Lesne; F Clerckx-Braun; P Duhoux; C van Ypersele de Strihou
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1982-08

2.  ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates.

Authors:  R D Brown; J E Manno
Journal:  J Pharm Sci       Date:  1978-12       Impact factor: 3.534

3.  Pharmacokinetics/pharmacodynamics of furosemide in man: a review.

Authors:  L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

4.  Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function.

Authors:  A Traeger; G Stein; H Sperschneider; E Keil
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-09

5.  Disposition and pharmacodynamics of diuretics and antihypertensive agents in renal disease.

Authors:  B L Mirkin; T P Green; R F O'Dea
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

6.  Pharmacological properties of the new potent diuretic torasemide in rats and dogs.

Authors:  A Ghys; J Denef; J M de Suray; M Gerin; A Georges; J Delarge; J Willems
Journal:  Arzneimittelforschung       Date:  1985
  6 in total
  7 in total

1.  Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure.

Authors:  H Spahn; H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.

Authors:  H Knauf; H Spahn; E Mutschler
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 4.  The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.

Authors:  T Risler; B Krämer; G A Müller
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 5.  Torasemide. A review of its pharmacological properties and therapeutic potential.

Authors:  H A Friedel; M M Buckley
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

6.  The influence of haemodialysis and haemofiltration on the clearance of torasemide in renal failure.

Authors:  G Loute; A Adam; P Ers; C Heremans; B Willems
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease.

Authors:  Darcy Adin; Kari Kurtz; Clarke Atkins; Mark G Papich; Shelly Vaden
Journal:  J Vet Intern Med       Date:  2019-11-26       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.